A post-marketing surveillance study for Repatha Inj. (evolocumab) in Korea text (20160156)

First published 25/07/2017

Last updated 05/06/2024

EU PAS number:

EUPAS19680

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Repatha PMS_20160156_ver 1 redacted

English (670.63 KB - PDF)View document

Study results

Study results

20160156 ORSR_Redacted

English (171.48 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents